Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Total thyroidectomy vs bilateral subtotal thyroidectomy Socioeconomic effects Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Bilateral subtotal thyroidectomy vs the Dunhill procedure Health‐related quality of life Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Bilateral subtotal thyroidectomy vs the Dunhill procedure Socioeconomic effects Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Total thyroidectomy vs subtotal thyroidectomy Health‐related quality of life Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Total thyroidectomy vs subtotal thyroidectomy Socioeconomic effects Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy (2015) · Cochrane | no estimate extracted | NR | No studies |
Gamma‐globulin vs control (saline or no treatment) Cases of congenital rubella infection ‐ not measured · susceptible people exposed to rubella Post‐exposure passive immunisation for preventing rubella and congenital rubella syndrome (2015) · Cochrane | no estimate extracted | NR | No studies |
Gamma‐globulin vs control (saline or no treatment) Cases of congenital rubella syndrome ‐ not measured · susceptible people exposed to rubella Post‐exposure passive immunisation for preventing rubella and congenital rubella syndrome (2015) · Cochrane | no estimate extracted | NR | No studies |
Gamma‐globulin vs control (saline or no treatment) Adverse events ‐ not measured · susceptible people exposed to rubella Post‐exposure passive immunisation for preventing rubella and congenital rubella syndrome (2015) · Cochrane | no estimate extracted | NR | No studies |
Capsaicin vs placebo Treatment‐related adverse events · non‐allergic rhinitis Capsaicin for non‐allergic rhinitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Capsaicin vs budesonide Treatment‐related adverse events · patients with non‐allergic rhinitis Capsaicin for non‐allergic rhinitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Five capsaicin treatments in one day vs daily capsaicin treatment Treatment‐related adverse events · patients with non‐allergic rhinitis Capsaicin for non‐allergic rhinitis (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL ACETATE vs PLACEBO Clinically significant response on psychotic symptoms ‐ as defined by each of the studies. · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL ACETATE vs PLACEBO Other adverse effects, general and specific · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL ACETATE vs PLACEBO Leaving the study early · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL ACETATE vs PLACEBO Average change in quality of life/satisfaction · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL ACETATE vs PLACEBO Significant change in quality of life/satisfaction ‐ as defined by each of the studies · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DECANOATE vs PLACEBO Clinically significant response on global state · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DECANOATE vs PLACEBO Relapse as defined by the studies · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DECANOATE vs PLACEBO Clinically significant response on psychotic symptoms ‐ as defined by each of the studies · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DECANOATE vs PLACEBO Other adverse effects, general and specific · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DECANOATE vs PLACEBO Leaving the study early · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DIHYDROCHLORIDE vs PLACEBO Relapse as defined by the studies · people with with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DECANOATE vs PLACEBO Average change in quality of life/satisfaction · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DECANOATE vs PLACEBO Significant change in quality of life/satisfaction ‐ as defined by each of the studies · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DIHYDROCHLORIDE vs PLACEBO Clinically significant response on psychotic symptoms ‐ as defined by each of the studies. · people with with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DIHYDROCHLORIDE vs PLACEBO Average change in quality of life/satisfaction · people with with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL DIHYDROCHLORIDE vs PLACEBO Significant change in quality of life/satisfaction ‐ as defined by each of the studies · people with with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL ACETATE vs PLACEBO Clinically significant response on global state · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
ZUCLOPENTHIXOL ACETATE vs PLACEBO Relapse as defined by the studies · people with schizophrenia Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane | no estimate extracted | NR | No studies |
Immunonutrition with probiotics and fibres vs control Systemic inflammatory response syndrome ‐ not reported · patients with acute pancreatitis Enteral nutrition formulations for acute pancreatitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Immunonutrition with probiotics and fibres vs control Organ failure ‐ not reported · patients with acute pancreatitis Enteral nutrition formulations for acute pancreatitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Immunonutrition with probiotics and fibres vs control Adverse events ‐ not reported · patients with acute pancreatitis Enteral nutrition formulations for acute pancreatitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Semi‐elemental enteral nutrition vs control Systemic inflammatory response syndrome ‐ not reported · patients with acute pancreatitis Enteral nutrition formulations for acute pancreatitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Semi‐elemental enteral nutrition vs control Organ failure ‐ not reported · patients with acute pancreatitis Enteral nutrition formulations for acute pancreatitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Semi‐elemental enteral nutrition vs control Adverse events ‐ not reported · patients with acute pancreatitis Enteral nutrition formulations for acute pancreatitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Fibre‐enriched enteral nutrition vs control Adverse events ‐ not reported · patients with acute pancreatitis Enteral nutrition formulations for acute pancreatitis (2015) · Cochrane | no estimate extracted | NR | No studies |
Plerixafor vs placebo Quality of life · People with haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple… Additional plerixafor to granulocyte colony‐stimulating factors for haematopoietic stem cell mobilisation… (2015) · Cochrane | no estimate extracted | NR | No studies |
Plerixafor vs placebo Progression‐free survival · People with haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple… Additional plerixafor to granulocyte colony‐stimulating factors for haematopoietic stem cell mobilisation… (2015) · Cochrane | no estimate extracted | NR | No studies |
Plerixafor vs placebo Time to engraftment · People with haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple… Additional plerixafor to granulocyte colony‐stimulating factors for haematopoietic stem cell mobilisation… (2015) · Cochrane | no estimate extracted | NR | No studies |
Plerixafor vs placebo Number of transplanted participants · People with haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple… Additional plerixafor to granulocyte colony‐stimulating factors for haematopoietic stem cell mobilisation… (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life · people with keratoconus Corneal collagen cross‐linking for treating keratoconus (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs lidocaine with adrenaline Adverse outcomes · patients with digital nerve blocks Adrenaline with lidocaine for digital nerve blocks (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs lidocaine with adrenaline Cost analysis · patients with digital nerve blocks Adrenaline with lidocaine for digital nerve blocks (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs lidocaine with adrenaline Duration of postoperative pain relief · patients with digital nerve blocks Adrenaline with lidocaine for digital nerve blocks (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR CI: confidence interval · Adolescent Idiopathic Scoliosis Surgical versus non‐surgical interventions in people with adolescent idiopathic scoliosis (2015) · Cochrane | no estimate extracted | NR | No studies |
Rapid COJEC vs standard induction therapies Progression‐free survival ‐ not reported · patients with high‐risk neuroblastoma Rapid COJEC versus standard induction therapies for high‐risk neuroblastoma (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: whole‐body cryotherapy (WBC) vs control (no WBC or passive rest) Adverse events · physically‐active adults partaking in exercise designed to produce delayed onset muscle soreness (most trial… Whole‐body cryotherapy (extreme cold air exposure) for preventing and treating muscle soreness after… (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + medroxyprogesterone acetate vs GnRH‐a ± placebo Quality of life · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + tibolone vs GnRH‐a ± placebo Uterine bleeding · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + raloxifene vs GnRH‐a ± placebo Rate of vasomotor symptoms · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |